Owlstone Medical Receives CE Mark Approval for ReCIVA™

News   Oct 05, 2016

 
Owlstone Medical Receives CE Mark Approval for ReCIVA™
 
 
 

RELATED ARTICLES

Self-powered, Paper-based Electrochemical Devices Developed for POC Diagnostics

News

The new paper-based diagnostic device detects biomarkers and identifies diseases by performing electrochemical analyses, and the assays change color to indicate specific test results.

READ MORE

New Test for Rare Immunodeficiency

News

Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency.

READ MORE

Using Saliva to Diagnose Zika

News

By analyzing the saliva of a pregnant mother infected with Zika and her twins, researchers were able to pinpoint the specific protein signature for Zika that is present in saliva, creating potential to use this signature as an effective way to screen for exposure.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE